GlaxoSmithKline has added three more lots of its Ventolin inhalers to its recent recall, bringing the total to more than 1.1 million units. According to a recent FDA Enforcement Report, the drugmaker ...

With sales of its respiratory drugs doing well, GlaxoSmithKline has been spending hundreds of millions of dollars to expand manufacturing of several kinds of inhalers. But a glitch at one of its ...

Reviewers examine the consequences of switching to hydrofluoroalkane, which is replacing chlorofluorocarbon, or CFC, as a key ingredient in albuterol inhalers designed to relieve asthma. The FDA has ...

For the millions of Americans afflicted with asthma, a concerning drug shortage has been going on since the summer of 2022. Liquid albuterol is in short supply, and one of the only domestic ...

Inhaler device errors are common and may impact the effectiveness of the delivered drug. There is a paucity of up-to-date systematic reviews (SRs) or meta-analyses (MAs) of device errors in asthma and ...

Several major manufacturing plants for the asthma and respiratory drug Albuterol have shut down, possibly worsening an already-flaring shortage of the medication that has forced hospitals to devise ...

A nationwide shortage of the asthma medication albuterol has been ongoing since last fall and experts fear it's only expected to get worse. Albuterol can be taken in several forms but it's the ...

As people with asthma know all too well, the cost of breathing more easily can be pretty steep—one “rescue” inhaler can cost $70 or more. Hopefully, those prices will finally drop with the ...

As hospitals give more and more COVID-19 patients albuterol to help them breathe, people with asthma may have a hard time getting an inhaler. The American College of Allergy, Asthma and Immunology ...

MUMBAI, India and WARREN, N.J., April 23, 2026 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA-EQ) (hereafter referred to as 'Cipla') and its wholly owned subsidiary Cipla USA Inc., (hereafter ...